SWEETENERS IN THE DIET AND THEIR HEALTH EFFECTS - p 8 - 10

  1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011.) Scientific Opinion on the substantiation of health claims related to intense sweeteners and contribution to the maintenance or achievement of a normal body weight (ID 1136, 1444, 4299), reduction of post‐prandial glycaemic responses (ID 4298), maintenance of normal blood glucose concentrations (ID 1221, 4298), and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 1134, 1167, 1283) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. https://doi.org/10.2903/j.efsa.2011.2229
  2. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to the sugar replacers xylitol, sorbitol, mannitol, maltitol, lactitol, isomalt, erythritol, D‐tagatose, isomaltulose, sucralose and polydextrose and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 463, 464, 563, 618, 647, 1182, 1591, 2907, 2921, 4300), and reduction of post‐prandial glycaemic responses (ID 617, 619, 669, 1590, 1762, 2903, 2908, 2920) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.https://doi.org/10.2903/j.efsa.2011.2076
  3. Rogers PJ et al (2016). Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies, Int J Obes (Lond). 40:381-94
  4. Ruiz-Ojeda et al (2019). Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials. Adv Nutr. 2019 Jan; 10 (Suppl 1): S31-S48. doi:10.1093/advances/nmy037
  5. Swanson KS, Gibson GR et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics

FOOD ALLERGY IN BREASTFED BABIES - pg 11 -16

  1. Public Health England. Statistical commentary: breastfeeding at 6 to 8 weeks, Quarter 3 October to December 2019 (April 2020 release). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/880354/2019_2020_Q3_Breastfeeding_Statistical_Commentary_FINAL.pdf. Accessed September 2020
  2. Infant Feeding Survey – UK (2010). Official statistics, National Statistics. https://files.digital.nhs.uk/publicationimport/pub08xxx/pub08694/infant-feeding-survey-2010-consolidated-report.pdf Accessed September 2020
  3. Schoemaker AA, Sprikkelman AB, Grimashaw KE et al. Incidence and natural history of challenge-proven cow’s milk allergy in European children – EuroPrevall birth cohort. Allergy. 2015;70 (8): 963-972
  4. Host A, Husby S, Osterballe O. A prospective study of cow’s milk allergy in exclusively breast-fed infants. Incidence, pathogenetic role of early inadvertent exposure to cow’s milk formula, and characterisation of bovine milk protein in human milk. Acta Paediatr Scand. 1988; 77 (5); 663-670
  5. Netting MJ, Middleton PF, Makrides M. Does maternal diet during pregnancy and lactation affect outcomes in offspring? A systematic review of food-based approaches. Nutrition. 2014; 30 (11-12): 1225-1241
  6. Lodge CJ. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015 Dec; 104(467): 38-53
  7. Greer FR, Sicherer SH, Burks A. Committee on nutrition, section on allergy and immunology. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019 Apr; 143(4)
  8. Jeurink P, Knipping K, Wiens F, Barańska K, Stahl B, Garssen J and Królak-Olejnik B. Importance of maternal diet in the training of the infant's immune system during gestation and lactation. Critical Reviews in Food Science and Nutrition. 2018. 59; 1-9
  9. Vance GH, Lewis SA, Grimshaw
  10. Martín-Muñoz MF, Pineda F, Parrado G et al. (2016). Food allergy in breastfeeding babies. Hidden allergens in human milk. Eur Ann Allergy Clin Immunol. 48. 123-128
  11. Macchiaverni P, Rekima A, Turfkruyer M, Mascarell L, Airouche S, Moingeon P, Adel-Patient K, Condino-Neto A, Annesi-Maesano I, Prescott S, Tulic M, Verhasselt V (2014). PD01 - Respiratory allergens in human milk: potential impact on susceptibility to allergic airway disease. Clinical and translational allergy. 4; p1. 10.1186/2045-7022-4-S1-P1
  12. Meyer R et al. Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper. Allergy. 2020 Jan; 75(1): 14-32
  13. Vadas P, Wai Y, Burks W, Perelman B. Detection of Peanut Allergens in Breast Milk of Lactating Women. 2001; 285(13): 1746-1748
  14. Palmer DJ, Gold MS, Makrides M. Effect of cooked and raw egg consumption on ovalbumin content of human milk: a randomised, double-blind, cross-over trial. Clin Exp Allergy. 2005; 35(2): 173-178
  15. Chirdo FG, Rumbo M, Añón MC, Fossati CA. Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand J Gastroenterol. 1998; 33(11): 1186-1192
  16. Matangkasombut P, Padungpak S, Thaloengsok S et al. Detection of β-lactoglobulin in human breast milk 7 days after cow milk ingestion. Paediatr Int Child Health. 2017; 37(3): 199-203
  17. Zhu J, Garrigues L, Toorn HV, Stahl B, Heck AJR. Discovery and Quantification of Nonhuman Proteins in Human Milk. Journal of Proteome Research. 18 (1), 225-238
  18. https://www.nationalbreastfeedinghelpline.org.uk/
  19. https://abm.me.uk/
  20. https://www.laleche.org.uk/

BREASTFEEDING AND WEANING: DISPELLING THE MYTHS - pg 17 - 20

  1. NHS (2020). Your breastfeeding questions answered – Your pregnancy and baby guide. Accessed on 3rd June 2020 at: https://www.nhs.uk/conditions/pregnancy-and-baby/your-breastfeeding-questions/
  2. Public Health England (2019). Official Statistics. Breastfeeding prevalence at 6-8 weeks after birth (Experimental Statistics) 2018/19 Annual Data Statistical Commentary (November 2019). Accessed on 3rd June 2020 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/845706/2018_2019_Annual_Breastfeeding_Statistical_Commentary.pdf
  3. NHS (2012). Infant Feeding Survey UK, 2010. Official statistics, National statistics, Survey, 20 Nov 2012. Accessed on 3rd June 2020 at: https://digital.nhs.uk/data-and-information/publications/statistical/infant-feeding-survey/infant-feeding-survey-uk-2010
  4. Lancet (2016). Breastfeeding Series Published: January 29, 2016. Accessed on 3rd June 2020 at: https://www.thelancet.com/series/breastfeeding
  5. Ferraro et al (2019). Timing of Food Introduction and the Risk of Food Allergy. Nutrients 2019 May; 11(5): 1131. Published online 2019 May 21. Accessed on 4th June 2020 at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567868/
  6. Coulthard et al (2009). Delayed Introduction of Lumpy Foods to Children During the Complementary Feeding Period Affects Child's Food Acceptance and Feeding at 7 Years of Age. Matern Child Nutr. 2009 Jan;5(1): 75-85. Accessed on 4th June 2020 at: https://pubmed.ncbi.nlm.nih.gov/19161546/
  7. 7 Chambers L (2016). Complementary feeding: Vegetables first, frequently and in variety. British Nutrition Foundation Nutrition Bulletin, 41, 142-146. Accessed 4th June 2020 at: https://onlinelibrary.wiley.com/doi/pdf/10.1111/nbu.12202
    8 Wardle et al (2003). Modifying children's food preferences: the effects of exposure and reward on acceptance of an unfamiliar vegetable. European Journal of Clinical Nutrition. Volume 57, pages 341-348. Accessed on 4th June 2020 at: https://www.nature.com/articles/1601541
    9 Du Toit et al (2015). Randomised Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. N Engl J Med. 2015 Feb 26; 372(9): 803-13. Accessed on 4th June 2020 at: https://pubmed.ncbi.nlm.nih.gov/25705822/
    10 Acas (2020). Pregnancy and maternity discrimination. Accessed on 4th June 2020 at: https://archive.acas.org.uk/index.aspx?articleid=5271#Adaptations%20at%20work%20to%20help%20pregnant%20employees%20and%20new%20mothers
    .

THE MICROBIOME, MICROFLORA AND PROBIOTICS - pg 21 - 24

  1. marketsandmarkets.com. Probiotic Ingredients Market by Function (Regular, Preventative, Therapy), Application (Food & Beverage, Dietary Supplements & Animal Probiotics), Ingredient (Bacteria & Yeast), and by Region - Global Trends & Forecast to 2020
  2. Lozupone CA, Stombaugh JI, Gordon JI and Knight R. Diversity, resilience and stability of the human gut microbiota. (2012) Nature 489 (7415) 220-230
  3. Goodrich JK, Waters JL., Poole AC et al (2014). Human genetics shape the gut microbiome. Cell 159:789-99
  4. Rothschild D, Weissbrod O, Barkan E et al (2018). Environment dominates over host genetics in shaping human gut microbiota. Nature 555:210-5
  5. Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ, Dijkstra G, Franke L, Xavier RJ, Jonkers D, Wijmenga C, Weersma RK, Zhernakova A (2016). Proton pump inhibitors affect the gut microbiome. Gut. 65(5): 740-748
  6. König J, Brummer RJ (2014). Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Benef Microbes. 5(3): 247-61
  7. Mujagic Z, Ludidi S, Keszthelyi D, Hesselink MA, Kruimel JW, Lenaerts K, Hanssen NM, Conchillo JM, Jonkers DM, Masclee AA (2014). Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacology and Thereupeutics. 40(3): 288-297
  8. Hasan MM, Brummer R, Rastall R, Weersma RK, Harmsen HJM, Faas M, Eggersdorfer M (2018). The role of the microbiome for human health: from basic science to clinical applications. European Journal of Nutrition. 57 (Supl 1) 1-14
  9. Liang D, Leung Ka-Kit R, Guan W, Au WW (2018). Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathogens. 10: 3
  10. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ (2006). Colonic health: fermentation and short chain fatty acids. Journal of Clinican Gastroenterology 40(3): 235-43
  11. De Vadder F, Kovatcheva-Datchary P, Goncalves D et al (2014). Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156: 84-96
  12. Tang WH, Wang Z, Levison BS et al (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 368: 1575-84
  13.  Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002
  14. Fredua-Agyeman M, Gaisford S (2015). Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry. Beneficia Microbes. 6(1): 141-151
  15. Moens F, Van den Abbeele P, Basit AW et al (2019). A four-strain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro. International Journal of Pharmaceutics. 555: 1-10
  16. Cremon C, Barbaro MR, Ventura M, Barbara G (2018). Pre-and probiotic overview. Current Opinion Pharmacology. 43, 87-92
  17. Santosa S, Farnworth E, Jones PJ (2006). Probiotics and their potential health claims. Nutrition Reviews. 64(6): 265-74
  18. Fontana L, Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gil A (2013). Sources, isolation, characterisation and evaluation of probiotics. British Journal of Nutrition. 109 (Suppl 2): S35-50
  19. Ceapa C, Davids M, Ritan J, Lambert J, Wels M, Douillard FP, Smokvina T, de vos WM, Knol J (2016). The Variable Regions of Lactobacillus rhamnosus Genomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires. Genome Biology and Evolution 8, 1889-1905
  20. Liang D, Ka-Kit Leung R, Guan W and W.Au W (2018). Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut pathogens. 10:3
  21. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T (2002). Gut bacteria and health foods - the European perspective. International journal of food microbiology. 78: 99-117
  22. Derrien M and Veiga P (2017). Rethinking diet to aid human-microbe symbiosis. Trends in Microbiology 25:2 p100-112
  23. Kristensen NB, Bryrup T, Allin KH et al (2016). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomised controlled trials. Genome Medicine 8, 52
  24.  Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM et al (2012). Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. (5): 611-22
  25.  McFarland LV (2014). Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 4(8)
  26.  National Institute for Health and Clinical Excellence (2015). Irritable bowel syndrome in adults. Diagnosis and management of irritable bowel syndrome in primary care. Clinical Guideline 61 Update 2015. Available at: http://www.nice.org.uk/Guidance/CG61
  27. Quigley E, Fried M, Gwee K et al (2016). World gastroenterology organisation global guidelines irritable bowel syndrome. Journal of Clinical Gastroenterology 50: 704-713
  28. Kerckhoffs AP, Samsom M, van der Rest ME et al (2009). Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World Journal of Gastroenterology.15(23): 2887-2892
  29. Parkes GC, Rayment NB, Hudpith BN et al (2012). Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterology and Motility. 24(1): 31-39
  30.  Jalanka-Tuovinen J, Salonen A, Nikkila J et al (2011). Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 6(7): e23035.https://doi.org/10.1371/journal.pone.0023035
  31. Fjeldheim Dale H, Rasmussen SH, Asiller OO and Lied GA (2019). Probiotics in Irritable Bowel Syndrome: an up-to-date Systematic Review. Nutrients 11(9) 2048
  32. Ishizuka A, Tomizuka K, Aoki R, Nishijima T, Saito Y, Inoue R, Ushida K, Mawatari T, Ikeda T (2012). Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans. Journal of Bioscience and Bioengineering 113 587-91
  33.  Matsumoto K, Takada T, Shimizu K, Kado Y, Kawakami K, Makino I, Yamaoka Y, Hirano K, Nishimura A, Kajimoto O et al (2006). The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomised placebo-controlled cross-over study. Bioscience and Microflora 25: 39 48
  34. Nobaek S, Johansson M, Molin G, Ahrne S, Jeppsson B (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology 95: 1231-1238
  35. Ki Cha B, Mun Jung S, Hwan Choi C, Song I, Woong Lee H, Joon Kim H (2011). The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled trial. Journal of Clinical Gastroenterology 46: 220-227
  36. Kim SE, Choi SC, Park KS, Park MI, Shin JE, Lee TH, Jung KW, Koo HS, Myung SJ (2015). Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation. Constipation Research group of Korean Society of Neurogastroenterology and Motility. Journal of Neurogastroenterology and Motility 21: 111. 20
  37. McNulty N, Yatsunenko T, Hsiao A, Faith J, Muegge B, Goodman A (2011). The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Science Translational Medicine 3: 106
  38. Staudacher HM, Lomer MC, Farquharson FM et al (2017). A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: A randomised controlled trial. Gastroenterology 153(4): 936-947
  39.  Hustoft T, Hausken T, Ystad S et al (2016). Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterology Motility 29(4)
  40. Selvaraj SM, Wong SH, Ser H-L et al (2020). Role of low-FODMAP diet and probiotics on gut microbiome in Irritable Bowel Syndrome (IBS). Progress in Microbes and Molecular Biology 3(1)

BARIATRIC SURGERY: REWARDS AND RISKS - pg 25 - 28

  1. World Obesity. Global overweight & obesity: prevalence of overweight and obesity in adults around the globe. London: World Obesity; 2015 [cited 2015 09 June]; Available from: http://www.worldobesity.org/aboutobesity/resources/obesity-data-portal/resources/tables/10/

  2. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016; 387(10026): 1377-96. pmid: 27115820

  3. Farb MG, Gokce N. Visceral adiposopathy: a vascular perspective. Horm Mol Biol Clin Investig. 2015; 21(2): 125-136. doi:10.1515/hmbci-2014-0047

  4. Tewari N, Awad S, Macdonald IA, Lobo DN. Obesity-related insulin resistance: implications for the surgical patient. Int J Obes (Lond) 2015; 39:1575-1588

  5. 5 Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue micro-environment and their impact on cardiovascular disease. Circ Res 2016;118: 1786-1807

  6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403

  7. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomised clinical trial. JAMA 2013; 309: 2240-2249

  8. Hutter MM, Schirmer BD, Jones DB et al. First report from the American College of Surgeons, Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254: 410-420; discussion 420-422 CrossRefPubMedGoogle Scholar

  9. Peterli R, Wölnerhanssen BK, Vetter D et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity: 3-year outcomes of the prospective randomised Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg 2017; 265:466-473 Google Scholar

  10. National Institute for Health and Care Excellence. NICE consults on updated recommendations for treating obesity, http://www.nice.org.uk/nice-consults-on-updated-recommendations-for-treating-obesity

  11. Health and Social Care Information Centre, Lifestyles Statistics. Statistics on obesity, physical activity and diet: England, 2014, [Internet], London, The Health and Social Care Information Centre. Available from: http://www.hscic.gov.uk/catalogue/PUB13648/Obes-phys-acti-diet-eng-2014-rep.pdf

  12. Higa K, Himpens J, Welbourn R, Dixon J, Kinsman R, Walton P. Third IFSO Global Registry Report 2017. Dendrite Clinical Systems Ltd, Henley-on-Thames, RG9 1AY, UK ISBN 978–0–9929942-4-2 2018

  13. Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013; 10: 575-584

  14. Casimiro I, Sam S, Brady MJ. Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones. Physiol Rep. 7 (10), 2019, e14111, https://doi.org/10.14814/phy2.14111

  15. Dimitriadis GK, Randeva MS and Miras AD (2017). Potential hormone mechanisms of bariatric surgery. Curr Obes Rep. 6: 253– 265

  16. 16 Hutch CR and Sandoval D (2017). The role of GLP‐1 in the metabolic success of bariatric surgery. Endocrinology 158: 4139– 4151

  17. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013; 273(3): 219-34. pmid:23163728

  18. Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311(22): 2297-304. pmid:24915261

  19. Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, Buob D, Pigeyre M, Mathurin P, Pattou F. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 2014; 260: 893-898; discussion 898-899 [PMID: 25379859 DOI: 10.1097/SLA.0000000000000945]

  20. Laursen TL, Hagemann CA, Wei C et al. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. World J Hepatol. 2019; 11(2): 138-149. doi:10.4254/wjh.v11.i2.138

  21. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010; (1): CD007340

  22. Dunaif AKR, Segal W, Futterweit and A Dobrjansky (1989). Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165–1174

  23. Sarwer DB, Spitzer JC, Wadden TA et al. Changes in sexual functioning and sex hormone levels in women following bariatric surgery. JAMA Surg. 2014; 149(1): 26-33. doi:10.1001/jamasurg.2013.5022

  24. Musella M, Milone M, Bellini M, Sosa Fernandez LM, Leongito M, Milone F. Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis. 2012; 8(4): 445-449. doi:10.1016/j.soard.2011.09.021

  25. DW Quyang (2017). Fertility and pregnancy after bariatric surgery. http://www.uptodate.com/contents/fertility-and-pregnancy-after-bariatric-surgery

  26. Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Preoperative nutritional deficiencies in severely obese bariatric candidates are not linked to gastric Helicobacter pylori infection. Obes Surg. 2013; 23:698-702. [PubMed] [DOI]

  27. Shikora SA, Kim JJ, Tarnoff ME. Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract. 2007; 22:29-40. [PubMed] [DOI]

  28. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition 2010; 26: 1031-1037 [PMID: 20363593 DOI: 10.1016/j.nut.2009.12.003]

  29. Weng TC, Chang CH, Dong YH, Chang YC, Chuang LM. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open 2015; 5: e006964

  30. Rousseau CS, Jean P, Gamache S, Lebel F, Mac-Way L, Biertho et al (2016). Change in fracture risk and fracture pattern after bariatric surgery: nested case-control

  31. Ko BJ, Myung SK, Cho KH, Park YG, Kim SG, Kim do H, Kim SM. Relationship Between Bariatric Surgery and Bone Mineral Density: a Meta-analysis. Obes Surg. 2016; 26:1414-1421. [PubMed] [DOI]

  32. Ivaska KK, Huovinen V, Soinio M, Hannukainen JC, Saunavaara V, Salminen P, Helmiö M, Parkkola R, Nuutila P, Kiviranta R. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone. 2017; 95:47-5

  33. Lupoli R, Lembo E, Saldalamacchia G, Avola CK, Angrisani L, Capaldo B. Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017; 8(11): 464-474. doi:10.4239/wjd.v8.i11.464 [PubMed]

  34. Milone M, Di Minno MN, Lupoli R, Maietta P, Bianco P, Pisapia A, Gaudioso D, Taffuri C. Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev 2014; 22: 223-229 [PMID: 24764323 DOI: 10.1002/erv.2292] [PMID: 26185175 DOI: 10.1136/ bmjopen-2014-006964]

  35. Papamargaritis D, Aasheim ET, Sampson B, le Roux CW. Copper, selenium and zinc levels after bariatric surgery in patients recommended to take multivitamin-mineral supplementation. J Trace Elem Med Biol. 2015; 31:167

  36. O’Kane M, Pinkney J, Aasheim E, Barth J, Batterham R, Welbourn R. BOMSS Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery. British Obesity and Metabolic Surgery Society [Internet].

  37. The National Bariatric Surgery Registry. https://nbsr.e-dendrite.com/

     


     

THE BARRIERS OF PANCREATIC EXOCRINE INSUFFICIENCY - pg 29 -31

  1. Shandro BM, Nagarajah R, Poullis A (2018). Challenges in the management of pancreatic exocrine insufficiency. World Journal of Gastrointestinal Pharmocology and Therapeutics. 9(5): 39-46
  2. Guts UK (2020). Retrieved from https://gutscharity.org.uk/advice-and-information/conditions/pancreatic-exocrine-insufficiency-pei-and-pancreatic-enzyme-replacement-therapy-pert/
  3. Domínguez-Muñoz JE et al (2011). Journal of Gastroenterology and Hepatology. 26 (Suppl 2): 12-16
  4. Creon.co.uk (2017). Effective dosing for PERT | Healthcare Professionals | Mylan [online]. Available at: http://creon.co.uk/effective-dosing/introduction-to-effective-dosing.html
  5. Forsmark Chris E. Chronic pancreatitis In: Sleisenger M, Fordtran J, Feldman M, Brandt L, and Friedman L. eds. Sleisenger & Fordtran’s Gastrointestinal and liver disease. 10th ed Philadelphia, PA: Saunders-Elsevier; 2016: 1020
  6. Imrie CW, Connett G, Hall RI, Charnley RM (2010). Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther. 32 (Suppl 1): 1-25
  7. Landers A, Muircroft W, Brown H. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer. BMJ Support Palliat Care. 2016; 6:75-79
  8. National Institute for Health and Care Excellence (2020). Pancreatic cancer in adults: diagnosis and management. Retrieved from https://www.nice.org.uk/guidance/ng85/chapter/Recommendations#nutritional-management
  9. Gan C, Chen YH, Liu L, Gao JH, Tong H, Tang CW, Liu R, Oncotarget. 2017. Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis. 8(55): 94920-94931
  10. Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA Lancet. 1995. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. 346(8985): 1247-51
  11. National Institute for Health and Care Excellence (2020). Retrieved from https://bnf.nice.org.uk/drug/pancreatin.html#sideEffects
  12. Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias-Garcia J, et al (2017). United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017; 5:153-199
  13. National Institute for Health and Care Excellence (2018). Pancreatitis. Retrieved from https://www.nice.org.uk/guidance/ng104

DYSPHAGIA: THE FACTS - pg 33 -35

  1. Cichero JAY, Lam P, Steele CM, Hanson B, Chen J, Dantas RO et al. Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management: The IDDSI Framework. Dysphagia [Internet]. 2016/12/02. 2017 Apr; 32(2): 293-314. Available from: https://pubmed.ncbi.nlm.nih.gov/27913916
  2. Royal College of Speech and Language Therapists (RCSLT) Clinical guidance: Dysphagia [Internet]. Available from: https://www.rcslt.org/members/clinical-guidance/dysphagia/dysphagia-guidance#section-17
  3. Verin E, Clavé P, Bonsignore MR, Marie JP, Bertolus C, Similowski T et al. Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. European Respiratory Journal [Internet]. 2017 Apr 1;49(4):1602530. Available from: http://erj.ersjournals.com/content/49/4/1602530.abstract
  4. Carrión S, Cabré M, Monteis R, Roca M, Palomera E, Serra-Prat M et al. Oropharyngeal dysphagia is a prevalent risk factor for malnutrition in a cohort of older patients admitted with an acute disease to a general hospital. Clinical Nutrition [Internet]. 2015 Jun 1;34(3): 436-42. Available from: https://doi.org/10.1016/j.clnu.2014.04.014
  5. Bath PM, Lee HS, Everton LF. Swallowing therapy for dysphagia in acute and subacute stroke. The Cochrane database of systematic reviews [Internet]. 2018 Oct 30;10(10):CD000323–CD000323. Available from: https://pubmed.ncbi.nlm.nih.gov/30376602
  6. Suttrup I, Warnecke T. Dysphagia in Parkinson’s Disease. Dysphagia [Internet]. 2016; 31(1): 24-32. Available from: https://doi.org/10.1007/s00455-015-9671-9
  7. Baijens LW, Clavé P, Cras P, Ekberg O, Forster A, Kolb GF et al. European Society for Swallowing Disorders – European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome. Clinical interventions in aging [Internet]. 2016 Oct 7; 11: 1403-28. Available from: https://pubmed.ncbi.nlm.nih.gov/27785002
  8. Shune SE, Karnell LH, Karnell MP, van Daele DJ, Funk GF. Association between severity of dysphagia and survival in patients with head and neck cancer. Head & neck [Internet]. 2011/08/30. 2012 Jun; 34(6): 776-84. Available from: https://pubmed.ncbi.nlm.nih.gov/22127835
  9. McKinstry A, Tranter M, Sweeney J. Outcomes of Dysphagia Intervention in a Pulmonary Rehabilitation Program. Dysphagia [Internet]. 2010; 25(2): 104-11. Available from: https://doi.org/10.1007/s00455-009-9230-3
  10. Chadwick DD, Jolliffe J. A descriptive investigation of dysphagia in adults with intellectual disabilities. Journal of Intellectual Disability Research [Internet]. 2009 Jan 1; 53(1): 29-43. Available from: https://doi.org/10.1111/j.1365-2788.2008.01115.x
  11. Hansen TS, Larsen K, Engberg AW. The Association of Functional Oral Intake and Pneumonia in Patients With Severe Traumatic Brain Injury. Archives of Physical Medicine and Rehabilitation [Internet]. 2008 Nov 1; 89(11): 2114-20. Available from: https://doi.org/10.1016/j.apmr.2008.04.013
  12. O’Loughlin G, Shanley C. Swallowing Problems in the Nursing Home: A Novel Training Response. Dysphagia [Internet]. 1998; 13(3): 172-83. Available from: https://doi.org/10.1007/PL00009569
  13. Matsuo K, Palmer JB. Anatomy and physiology of feeding and swallowing: normal and abnormal. Physical medicine and rehabilitation clinics of North America [Internet]. 2008 Nov; 19(4): 691–vii. Available from: https://pubmed.ncbi.nlm.nih.gov/18940636
  14. O’Keeffe ST. Use of modified diets to prevent aspiration in oropharyngeal dysphagia: is current practice justified? BMC Geriatrics [Internet]. 2018; 18(1): 167. Available from: https://doi.org/10.1186/s12877-018-0839-7
  15. Tagliaferri S, Lauretani F, Pelá G, Meschi T, Maggio M. The risk of dysphagia is associated with malnutrition and poor functional outcomes in a large population of outpatient older individuals. Clinical Nutrition [Internet]. 2019; 38(6): 2684-9. Available from: http://www.sciencedirect.com/science/article/pii/S026156141832555X
  16. Reber E, Gomes F, Dähn IA, Vasiloglou MF, Stanga Z. Management of Dehydration in Patients Suffering Swallowing Difficulties. Journal of clinical medicine [Internet]. 2019 Nov 8; 8(11): 1923. Available from: https://pubmed.ncbi.nlm.nih.gov/31717441
  17. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics [Internet]. 2005 Mar 1; 61(3): 772-8. Available from: https://doi.org/10.1016/j.ijrobp.2004.06.017
  18. Wright L, Cotter D, Hickson M, Frost G. Comparison of energy and protein intakes of older people consuming a texture modified diet with a normal hospital diet. Journal of Human Nutrition and Dietetics [Internet]. 2005 Jun 1; 18(3): 213-9. Available from: https://doi.org/10.1111/j.1365-277X.2005.00605.x
  19. © The International Dysphagia Diet Standardisation Initiative 2019 @ https://iddsi.org/framework. Licensed under the CreativeCommons Attribution Sharealike 4.0 License https://creativecommons.org/licenses/by-sa/4.0/legalcode. Derivative works extending beyond language translation are NOT PERMITTED.

DELAYED ONSET MUSCLE SORENESS (DOMS): THE ROLE OF NUTRITION - pg 39 - 40

  1. Logue et al. (2018) ‘Low energy availability in athletes: A review of prevalence, dietary patterns, physiological health and sports performance’, Sports Medicine, 48(1), pp. 73-96.
  2. Kim, J., & Lee, J. (2014). A review of nutritional intervention on delayed onset muscle soreness. Part I. Journal of exercise rehabilitation, 10(6), 349.
  3. Poole, C., Wilborn, C., Taylor, L., & Kerksick, C. (2010). The role of post-exercise nutrient administration on muscle protein synthesis and glycogen synthesis. Journal of Sports Science & Medicine, 9(3), 354.
  4. Rodriguez, N. R., Di Marco, N. M., Langley, S., American Dietetic Association, & American College of Sports Medicine. (2009). American College of Sports Medicine position stand. Nutrition and athletic performance. Medicine and science in sports and exercise, 41(3), 709.
  5. Symons, T. B., Sheffield-Moore, M., Wolfe, R. R., & Paddon-Jones, D. (2009). A moderate serving of high-quality protein maximally stimulates skeletal muscle protein synthesis in young and elderly subjects. Journal of the American Dietetic Association, 109(9), 1582-1586.
  6. Hurley, C. F., Hatfield, D. L., & Riebe, D. A. (2013). The effect of caffeine ingestion on delayed onset muscle soreness. The Journal of Strength & Conditioning Research, 27(11), 3101-3109.
  7. Tartibian, B., Maleki, B. H., & Abbasi, A. (2011). Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men. Clinical Journal of Sport Medicine, 21(2), 131-137.
  8. Corder, K. E., Newsham, K. R., McDaniel, J. L., Ezekiel, U. R., & Weiss, E. P. (2016). Effects of short-term docosahexaenoic acid supplementation on markers of inflammation after eccentric strength exercise in women. Journal of sports science & medicine, 15(1), 176.

HOME ENTERAL FEEDING: DISCUSSING THE ESPEN GUIDELINE - pg 41 - 43

  1. NICE (2006). CG32. Nutrition support for adults-oral nutrition support, enteral tube feeding and parenteral nutrition
  2. https://www.espen.org/espen/aims (Taken 20.08.20)
  3. Bischoff SC et al. ESPEN guideline on home enteral nutrition. Clinical Nutrition, 39 (2020) 5-22
  4. Loser et al (2005). ESPEN guidelines on artificial enteral nutrition - percutaneous endoscopic gastrostomy (PEG). Clinical Nutrition 24: 848-861
  5. National Nurses Nutrition Group (NNNG). Good Practice Consensus Guideline - Exit site management for gastrostomy tubes in adults and children. UK, 2013
  6. Bennell J (2018). Buried bumper syndrome: do we have enough evidence? Br J Community Nurs 23: S28-S30
  7. Lanarkshire Enteral Feeding Group (2018). Best Practice Statements for Adults.
  8. McClave et al (2016). ACG Clinical guideline on nutrition therapy in the adult hospitalised patient. Am J Gastroenterol, 111:315-34
  9. Slau K, Troth T, Gibson E et al. How long do percutaneous endoscopic gastrostomy feeding tubes last? A retrospective analysis. Postgraduate Medical Journal 2018, 94: 469-474
  10. Toussaint et al (2015). Enteral access in adults. Clin Nutr 34: 350-8
  11.  Villela et al.(2014). Endoscopic gastrostomy replacement tubes: long-term randomised trial with five silicone commercial models. Clin Nutr 33:221-5

 

THE INTEGRATED AUTISM SERVICE (CARDIFF AND VALE) - p44 - 46

  1. National Autistic Society. What is Autism? https://www.autism.org.uk/about/what-is/myths-facts-stats.aspx retrieved 16th July 2020
  2.  National Autistic Society. Autism facts and history. https://www.autism.org.uk/about/what-is/myths-facts-stats.aspx retrieved 16th July 2020
  3. Welsh Government. (2016). Refreshed Autistic Spectrum Disorder Strategic Action Plan available at: http://www.asdinfowales.co.uk/resource/161130ASD-actionplanen.pdf retrieved 16th July 2020
  4. Welsh Government (2016). The Assessment and Diagnosis of Adults with Autistic Spectrum Disorder in Wales. The Report of the ASD Adult Diagnostic Task and Finish Group, April 2016
  5. Hirvikoski T et al (2015). Premature mortality in autism spectrum disorder. The British Journal of Psychiatry, 207(5)
  6. Croen LA, Zerbo O, Qian Y et al (2015). The health status of adults on the autism spectrum. Autism 2015; 19:814-823
  7. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th Edition). Washington, DC
  8. Fraker C et al (2009). Food Chaining: The Proven 6-Step Plan to Stop Picky Eating, Solve Feeding Problems, and Expand Your Child's Diet. London:Hachette Books
  9. Miller WR and Rollnick S (2013). Motivational interviewing: helping people change. Applications of motivational interviewing (3rd ed.). New York: Guilford Press
  10. Prochaska JO and DiClemente CC (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390-395
  11. Outcomes Star(™) Copyright © 2020. Triangle Consulting Social Enterprise Limited. All rights reserved. https://www.outcomesstar.org.uk/ retrieved 16th July 2020
  12. Autistica. Treating anorexia in autistic women. https://www.autistica.org.uk/our-research/research-projects/treating-anorexia-in-autistic-women retrieved 16th July 2020
  13. Thomas JJ, Wons OB and Eddy KT (2018). Cognitive-behavioral treatment of avoidant/restrictive food intake disorder. Current opinion in psychiatry, 31(6), 425-430. https://doi.org/10.1097/YCO.0000000000000454
  14. Goldschmidt J, Song HJ (2015). At-Risk and Under-served: A Proposed Role for Nutrition in the Adult Trajectory of Autism. J Acad Nutr Diet. 2015; 115(7): 1041-1047

 

SETTING UP A SPECIALIST DIETETIC SERVICE - p47 - 49

  1. Diabetes and Mental Illness: Improving Outcomes and Services 2020. DIAMONDS Study – CLAHRC Yorkshire And Humber [online]. Available at: http://www.diamonds.nihr.ac.uk/ [Accessed 31 July 2020]
  2. Carey M, Barnett J, Doherty Y, Barnard K, Daly H, French P, Gossage-Worrall R, Hadjiconstantinou M, Hind D, Mitchell J, Northern A, Pendlebury J, Rathod S, Shiers D, Taylor C and Holt R (2018). Reducing weight gain in people with schizophrenia, schizoaffective disorder, and first episode psychosis: describing the process of developing the STructured lifestyle Education for People With SchizophrEnia (STEPWISE) intervention. Pilot and Feasibility Studies, 4(1)
  3. Clinical Support System for Serious Mental Illness. [online]. Available at: https://www.psychiatry.org/psychiatrists/education/signature-initiatives/css-smi [Accessed 31 July 2020]
  4. De Hert M, Correll C, Bobes,J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller H, Ndetei D, Newcomer J, Uwakwe R and Leucht, S (2011a). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), p 52-77
  5. The National Institute for Health and Care Excellence (2014). Quality Statement 6: Physical Health Checks For People With Serious Mental Illness. Promoting Health and Preventing Premature Mortality In Black, Asian and Other Minority Ethnic Groups. Quality Standards | NICE [online]. Available at: https://www.nice.org.uk/guidance/qs167/chapter/Quality-statement-6-Physical-health-checks-for-people-with-serious-mental-illness [Accessed 31 July 2020]
  6.  De Hert M, Correll C, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller H, Ndetei D, Newcomer J, Uwakwe R and Leucht S (2011b). Physical illness in patients with severe mental disorders. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), p 52-77
  7. Lean M and Pajonk F (2003). Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes. Diabetes Care, 26(5), p 1597-1605
  8.  Cohen D (2016). Antipsychotic-Related Mortality. Life-Threatening Effects of Antipsychotic Drugs, p 311-332
  9. De Hert M, Correll C, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller H, Ndetei D, Newcomer J, Uwakwe R and Leucht S (2011c). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), p 52-77
  10. Cohen A (2018). Diabetes and Severe Mental Illness. GM [online]. Available at: https://www.gmjournal.co.uk/diabetes-and-severe-mental-illness [Accessed 31 July 2020]
  11. NHS England (2018). Improving Physical Healthcare for People Living With Severe Mental Illness (SMI) In Primary Care [online]. Available at: https://www.england.nhs.uk/wp-content/uploads/2018/02/improving-physical-health-care-for-smi-in-primary-care.pdf [Accessed 31 July 2020]
  12.  Balhara Y (2011). Diabetes and psychiatric disorders. Indian Journal of Endocrinology and Metabolism, 15(4), p 274
  13. Diabetes UK (2017) [online]. Diabetes UK. Available at: https://www.diabetes.org.uk/about_us/news/three-in-five-people-with-diabetes-experience-emotional-or-mental-health-problems [Accessed 31 July 2020]
  14. Diabetes UK (2019). Diabetes And Emotional Health [online] p65. Available at: https://www.diabetes.org.uk/professionals/resources/shared-practice/psychological-care/emotional-health-professionals-guide/chapter-3-diabetes-distress#:~:text=The%20Problem%20Areas%20In%20Diabetes%20(PAID)%20is%20a%2020%2D,4%20(a%20serious%20problem) [Accessed 31 July 2020]